Spyre Therapeutics Inc (SYRE)

Stock-Based Compensation

$13.51M

Quarterly · Period ending: · USD

SYRE logo

SYRE Stock-Based Compensation

Latest reported$13.51M
SYRE Quarterly Stock-Based Comp ($0.00 → $13.51M)
High-resolution chart · PNG

SYRE stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
13,512,000
12,806,000
9,811,000
9,566,000
9,378,000
8,859,000
9,216,000
13,100,000
8,682,000
13,835,000
17,270,000
4,785,000
1,911,000
1,709,000
1,427,000
1,566,000
2,017,000
2,101,000
2,094,000
2,107,000
2,080,000
1,757,000
1,612,000
1,696,000
1,600,000
1,348,000
1,184,000
1,366,000
1,245,000
1,081,000
1,377,000
1,072,000
996,000
835,000
698,000
728,000
665,000
401,000
258,000
434,000
389,000
140,000
419,000
164,000
146,000
38,000
69,000
3,000
75,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.